Moolec Science (MLECW) Amortization - Intangibles (2023 - 2024)
Moolec Science (MLECW) posted Amortization - Intangibles of -$131756.0 for Q3 2024, up 0.81% sequentially from -$132826.0 in Q1 2024, and up 4.6% YoY from -$125960.1 in Q4 2023.
Moolec Science (MLECW) Amortization - Intangibles (2023 - 2024) Analysis & Trends
Moolec Science has reported Amortization - Intangibles for 2 years, with the latest figure at -$131756.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,756.00 |
| Mar 31, 2024 | -132,826.00 |
| Dec 31, 2023 | -142,218.00 |
| Sep 30, 2023 | -138,111.00 |